Evolution of the Average Target: Harmonic Inc.

Evolution of the Target Price: Harmonic Inc.

Changes in Analyst Recommendations: Harmonic Inc.

43ca6738bebeeb1ebdc6fe7e.10KzOdo3QvXxc_zGfnfuQDYbvpMSy9LKjmc-d836NA4.nDGHUuNEHZ2LCqSTCBqKMHJE0PxXorrzwCxnGa6MYlumeuZdllEax58ZqQ~319009247706115cdfe84a9634159a19
01-16 Top Midday Stories: BlackRock Rises on Q4 Results; Amazon Challenges Saks Global Chapter 11 Plan; Ford-BYD Potential Deal MT
29/07/25 Harmonic Q2 revenue, adjusted EPS beat expectations RE
08/07/25 Wolfe Initiates Harmonic at Underperform With $7 Price Target MT
10/01/25 Barclays Downgrades Harmonic to Equalweight From Overweight, Adjusts Price Target to $14 From $17 MT
09/01/25 Barclays Downgrades Harmonic to Equalweight From Overweight, Adjusts Price Target to $14 From $17 MT
29/10/24 Jefferies Downgrades Harmonic to Hold From Buy, Price Target is $12.50 MT
29/10/24 Raymond James Downgrades Harmonic to Outperform From Strong Buy, Price Target is $14 MT
30/01/24 Raymond James Trims Price Target on Harmonic to $18 From $19, Maintains Strong Buy Rating MT
30/01/24 Rosenblatt Securities Cuts Harmonic Price Target to $16 From $18, Maintains Buy Rating MT
01/11/23 Barclays Adjusts Price Target on Harmonic to $14 From $20, Maintains Overweight Rating MT
10/08/23 Raymond James Upgrades Harmonic to Strong Buy From Outperform, Adjusts Price Target to $16 From $15 MT
01/08/23 Jefferies Adjusts Harmonic Price Target to $18 From $19, Maintains Buy Rating MT
01/08/23 Raymond James Adjusts Price Target on Harmonic to $15 From $17, Maintains Outperform Rating MT
01/08/23 Rosenblatt Securities Adjusts Harmonic Price Target to $18 From $22, Maintains Buy Rating MT
01/08/23 Needham Adjusts Harmonic's Price Target to $18 From $21, Keeps Buy Rating MT
01/08/23 Barclays Adjusts Harmonic's Price Target to $20 From $23, Keeps Overweight Rating MT
09/05/23 Rosenblatt Adjusts Price Target on Harmonic to $22 From $20, Maintains Buy Rating MT
09/05/23 Barclays Adjusts Price Target on Harmonic to $23 From $20, Keeps Overweight Rating MT
21/03/23 Northland Securities Adjusts Price Target on Harmonic to $23 From $20, Keeps Outperform Rating MT
31/01/23 Raymond James Adjusts Harmonic Price Target to $17 From $18, Maintains Outperform Rating MT
31/01/23 Barclays Adjusts Harmonic's Price Target to $20 From $17, Keeps Overweight Rating MT
24/01/23 Needham Adjusts Price Target on Harmonic to $19 From $17, Maintains Buy Rating MT
09/01/23 Jefferies Upgrades Harmonic to Buy From Hold, Price Target is $19 MT
16/12/22 LifeSci Capital Downgrades Third Harmonic Bio to Market Perform From Outperform MT
16/12/22 Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Slashes Price Target to $5 From $34 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+46.89%
+28.96%
+18.9%
+45.57%
+50.91%
+22.67%
+14.44%
-21.72%
+5.01%
+45.21%
Average +25.68%
Weighted average by Cap. +28.13%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
10.99USD
Average target price
16.14USD
Spread / Average Target
+46.89%
High Price Target
20.00USD
Spread / Highest target
+81.98%
Low Price Target
8.000USD
Spread / Lowest Target
-27.21%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. HLIT Stock
  4. Consensus Harmonic Inc.